Is Response to Prophylactic Lithium a Familial Trait?
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Selecting a drug according to the treatment response in a relative has been widely accepted advice in the management of mood disorders. However, this recommendation has not been adequately substantiated in the literature. We tested the hypothesis that response to long-term lithium treatment is a familial trait. METHOD: We compared response to long-term lithium treatment in bipolar relatives of bipolar lithium responders and bipolar controls. Twenty-four relatives with bipolar disorder (as determined using the Schedule for Affective Disorders and Schizophrenia-Lifetime version [SADS-L] and Research Diagnostic Criteria [RDC]) were identified in families of 106 patients with lithium-responsive bipolar disorder. A consecutive series of 40 lithium-treated patients in a bipolar clinic (meeting RDC and DSM-IV criteria for bipolar disorder) served as a comparison group. Lithium response was evaluated on a rating scale reflecting the quality and quantity of available data. RESULTS: The prevalence of unequivocal response among the relatives was 67%, as compared with the response rate of 35% in the comparison group (chi2 = 6.04, df = 1, p = .014). CONCLUSION: This highly significant difference in response between relatives and the control group supports the view that the response to lithium prophylaxis clusters in families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with a study showing that patients who have a lithium‐responsive relative have a 67% likelihood of also being lithium responsive, versus 35% of those without a responsive relative.417”
Citations
Cites
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
Kaplan and Sadock's synopsis of psychiatry
Sadock, B. J., & Sadock, V. A. (1998) · Cited by 450
Relationship Between the Effectiveness of Lithium Therapy and Family History
MENDLEWICZ, J., FIEVE, R. R., & STALLONE, F. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.9.1011 · Cited by 166
DIFFERENTIATION OF TWO GENETICALLY SPECIFIC TYPES OF DEPRESSION BY THE RESPONSE TO ANTI-DEPRESSANTS
Pare, C. M. B., Rees, L., & Sainsbury, M. J. (1962) · The Lancet · doi:10.1016/s0140-6736(62)91019-x · Cited by 165
Does Lithium Treatment Still Work?: Evidence of Stable Responses Over Three Decades
Baldessarini, R. J., & Tondo, L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.187 · Cited by 164
Lithium response and genetics of affective disorders
Grof, P., Alda, M., Gror, E., Zvolsky, P., & Walsh, M. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90066-3 · Cited by 161
Self-citationFamilial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
Franchini, L., Serretti, A., Gasperini, M., & Smeraldi, E. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00004-1 · Cited by 156
Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorder
Turecki, G., Grof, P., Cavazzoni, P. A., Duffy, A. C., Grof, E., Ahrens, B., Berghöfer, A., Müller-Oerlinghausen, B., Dvorakova, M. C., Libigerová, E., et al. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000447 · Cited by 127
Self-citationPharmacogenetic response to antidepressants in a multicase family with affective disorder
O’Reilly, R. L., Bogue, L., & Singh, S. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90642-4 · Cited by 116
Cited by
Items 101–200 of 443
Milanesi, E., Hadar, A., Maffioletti, E., Werner, H., Shomron, N., Gennarelli, M., Schulze, T. G., Costa, M. F., Zompo, M. D., Squassina, A., et al. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0523-8 · Cited by 45
“Lithium salts are a wellestablished treatment in the management of BD; however, about 50–60 % of patients do not respond sufficiently and require a change to another mood stabilizing drug such as valproate or carbamazepine (Yildiz et al. 2011).”
BackgroundMethodNew Developments in the Genetics of Bipolar Disorder
Shinozaki, G., & Potash, J. B. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0493-5 · Cited by 55
Lithium Pharmacogenetics: Where Do We Stand?
Pisanu, C., Melis, C., & Squassina, A. (2016) · Drug Development Research · doi:10.1002/ddr.21341 · Cited by 42
“Lithium responders often present a familial history of BPD and of lithium response [Alda, 2015; Alda et al., 1997; Alda et al., 1994; Grof et al., 2002].”
Telomere length in bipolar disorder and lithium response
Squassina, A., Pisanu, C., Corbett, N., & Alda, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.008 · Cited by 51
“In the study by Martinsson and colleagues (2013) BD patients were characterized for lithium response according to the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder (Grof et al., 2002).”
MethodSelf-citationPersonalized management of bipolar disorder
Alda, M., & Manchia, M. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.005 · Cited by 54
Self-citationPahwa, M., Joseph, B., Núñez, N. A., Jenkins, G. D., Colby, C. L., KASHANI, K. B., Veldić, M., Moore, K. M., Betcher, H. K., Özerdem, A., et al. (2021) · Bipolar Disorders · doi:10.1111/bdi.13052 · Cited by 50
Wang, J., Shamah, S. M., Sun, A. X., Waldman, I. D., Haggarty, S. J., & Perlis, R. H. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.72 · Cited by 44
3D 7Li magnetic resonance imaging of brain lithium distribution in bipolar disorder
Smith, F. E., Thelwall, P. E., Necus, J., Flowers, C. J., Blamire, A. M., & Cousins, D. A. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0016-6 · Cited by 42
“Response to lithium was determined using the Retrospective Evaluation of Lithium Response (Alda scale) [16] and non-target effects were gauged using the Lithium Side Effects Rating Scale (LISERS) [17].”
MethodPisanu, C., Papadima, E. M., Melis, C., Congiu, D., Loizedda, A., Orrù, N., Calza, S., Orrù, S., Carcassi, C., Severino, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236040 · Cited by 44
“Clinical response to maintenance treatment with lithium was evaluated using the “Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder” (Alda scale) [49,50], as previously described [23].”
MethodManchia, M., Squassina, A., Congiu, D., Chillotti, C., Ardau, R., Severino, G., & Zompo, M. D. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.003 · Cited by 47
Grande, I., de Arce, R., Jiménez-Arriero, M. Á., Lorenzo, F. G. I., Valverde, J. I. F., Balanzá-Martínez, V., Zaragoza, S., Cobaleda, S., & Vieta, E. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000405 · Cited by 42
Amare, A. T., Thalamuthu, A., Schubert, K. O., Fullerton, J. M., Ahmed, M. B., Hartmann, S., Papiol, S., Heilbronner, U., Degenhardt, F., Ayele, F. T., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02149-1 · Cited by 44
Self-citationCan the response to mood stabilizers be predicted in bipolar disorder
Geoffroy, P. A., Bellivier, F., Leboyer, M., & Etain, B. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e696 · Cited by 41
“Various evidence indicates that the response to longterm lithium treatment is a familial trait and clusters in families (10).”
BackgroundMethodInfluentialPaul, P., Iyer, S., Nadella, R. K., Nayak, R., Chellappa, A. S., Ambardar, S., Sud, R., Sukumaran, S. K., Purushottam, M., Jain, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64202-1 · Cited by 39
Lin, C., Chen, M., Chou, L., Lin, C., Chen, C., & Lane, H. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.12.003 · Cited by 44
“(McGlashan, 1986; Duggan et al., 1998; Grof et al., 2002), involuntary hospitalization”
BackgroundPharmacogenomic aspects of bipolar disorder: An update
Budde, M., Degner, D., Brockmöller, J., & Schulze, T. G. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.02.001 · Cited by 41
Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research
Damba, J. J., Bodenstein, K., Lavín, P., Drury, J., Sekhon, H., Renoux, C., Trinh, E., Rej, S., & Greenway, K. T. (2022) · CNS Drugs · doi:10.1007/s40263-022-00952-y · Cited by 43
“Potential kidney harms from lithium must also be balanced against its benefits as it remains the gold standard in BAD; for example, 30–40% of patients with BAD preferentially respond to lithium relative to other agents [101].”
BackgroundLv, Q., Hu, Q., Zhang, W., Huang, X., Zhu, M., Geng, R., Cheng, X., Bao, C., Wang, Y., Zhang, C., et al. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa003 · Cited by 41
“Response to ECT in bipolar mania was defined as a YMRS score reduction rate of ≥50% or a YMRS score = 12 (Grof et al., 2002; Lv et al., 2019).”
BackgroundTemperament, life events, and psychopathology among the offspring of bipolar parents
Duffy, A. C., Alda, M., Trinneer, A., Demidenko, N., Grof, P., & Goodyer, I. M. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0592-x · Cited by 41
Self-citationThe diacylglycerol kinase eta gene and bipolar disorder: a replication study in a Sardinian sample
Squassina, A., Manchia, M., Congiu, D., Severino, G., Chillotti, C., Ardau, R., Piccardi, M. P., & Zompo, M. D. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.93 · Cited by 37
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder
Galimberti, D., Reif, A., Dell'Osso, B., Palazzo, C., Villa, C., Fenoglio, C., Kittel‐Schneider, S., Leonhard, C., Olmes, D. G., Serpente, M., et al. (2014) · Bipolar Disorders · doi:10.1111/bdi.12169 · Cited by 36
“She showed good response to lithium treatment, according to an Alda score of 7 (9), and there were no psychotic symptoms or any documented suicide attempts.”
Masui, T., Hashimoto, R., Kusumi, I., Suzuki, K., Tanaka, T., Nakagawa, S., Suzuki, T., Iwata, N., Ozaki, N., Kato, T., et al. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.010 · Cited by 36
Who are excellent lithium responders and why do they matter?
Alda, M. (2017) · World Psychiatry · doi:10.1002/wps.20462 · Cited by 36
Self-citationAnalysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder
Reinbold, C. S., Forstner, A. J., Hecker, J., Fullerton, J. M., Hoffmann, P., Hou, L., Heilbronner, U., Degenhardt, F., Adli, M., Akiyama, K., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00207 · Cited by 37
“Evidence suggests that some of the variability in lithium response has a genetic basis (11, 12).”
BackgroundSelf-citationOn behalf of the ISBD-IGSLI Joint Task Force on Lithium Treatment, Laroche, D. G., Étain, B., Severus, E., Scott, J. L., & Bellivier, F. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-020-00203-3 · Cited by 35
Mood Stabilizers and the Influence on Global Leukocyte DNA Methylation in Bipolar Disorder
Backlund, L., Wei, Y. B., Martinsson, L., Melas, P. A., Liu, J. J., Mu, N., Östenson, C., Ekström, T. J., Schalling, M., & Lavebratt, C. (2015) · Complex Psychiatry · doi:10.1159/000430867 · Cited by 41
Post, R. M., Leverich, G. S., Kupka, R., Keck, P. E., McElroy, S. L., Altshuler, L. L., Frye, M. A., Rowe, M., Grunze, H., Suppes, T. M., et al. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.01.009 · Cited by 37
“However, lithium was used less often in patients with a positive parental history of mood disorder despite reports that such a positive family history is a predictor of good responsiveness [23,24] (10).”
BackgroundRapid cycling bipolar disorders in primary and tertiary care treated patients
Hájek, T., Hahn, M., Slaney, C., Garnham, J. S., Green, J., Růžičková, M., Zvolský, P., & Alda, M. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00587.x · Cited by 35
“Lifetime treatment response to lithium, carbamazepine, valproate, lamotrigine, and olanzapine was determined in both the primary and tertiary care treated subjects, using the previously described scale (17).”
MethodSelf-citationManagement Options for Bipolar Disorder in Children and Adolescents
Danielyan, A., & Kowatch, R. A. (2005) · Pediatric Drugs · doi:10.2165/00148581-200507050-00002 · Cited by 35
Lithium response in bipolar disorder: Genetics, genomics, and beyond
Papiol, S., Schulze, T. G., & Heilbronner, U. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136786 · Cited by 40
hTERT genetic variation in depression
Wei, Y. B., Martinsson, L., Liu, J. J., Forsell, Y., Schalling, M., Backlund, L., & Lavebratt, C. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.025 · Cited by 37
Fornaro, M., Berardis, D. D., Anastasia, A., Novello, S., Fusco, A., Cattaneo, C. I., Solmi, M., Monaco, F., Veronese, N., Kim, Y., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.034 · Cited by 35
“As an example, the Alda rating scale was regarded as an optimal tool for such outcomes (Grof et al., 2002) .”
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder
Nunes, A., Stone, W., Ardau, R., Berghöfer, A., Bocchetta, A., Chillotti, C., Deiana, V., Degenhardt, F., Forstner, A. J., Garnham, J. S., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01148-y · Cited by 36
Self-citationLuykx, J. J., Boks, M. P., Terwindt, A. P. R., Bakker, S. C., Kahn, R. S., & Ophoff, R. A. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.008 · Cited by 33
“Several family studies suggest that response to Li is heritable (Engstrom et al., 1997; Grof et al., 2002).”
Scott, J. L., Geoffroy, P. A., Sportiche, S., Brichant‐Petitjean, C., Gard, S., Kahn, J., Azorin, J., Henry, C., Étain, B., & Bellivier, F. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.069 · Cited by 32
Twenty years of Lithium pharmacogenetics: A systematic review
Pagani, R., Gasparini, A., Ielmini, M., Caselli, I., Poloni, N., Ferrari, M., Marino, F., & Callegari, C. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.05.036 · Cited by 32
Mora, E., Portella, M. J., Forcada, I., Vieta, E., & Mur, M. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.07.008 · Cited by 34
“Treatment response was assessed using the 11-point Alda scale that measures the extent of improvement during long-term treatment and weighs clinical factors considered relevant for determining whether or not the observed improvement is due to lithium treatment [17,18].”
MethodBareš, M., Novák, T., Brunovský, M., Kopeček, M., Stopková, P., Krajca, V., & Höschl, C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.006 · Cited by 27
Stacey, D., Schubert, K. O., Clark, S. R., Amare, A. T., Milanesi, E., Maj, C., Leckband, S. G., Shekhtman, T., Kelsoe, J. R., Gurwitz, D., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0237-0 · Cited by 32
Pharmacogenomics of Bipolar Disorder
Severino, G., Squassina, A., Costa, M. F., Pisanu, C., Calza, S., Alda, M., Zompo, M. D., & Manchia, M. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.51 · Cited by 33
Self-citationSquassina, A., Congiu, D., Manconi, F., Manchia, M., Chillotti, C., Lampus, S. F., Severino, G., & Zompo, M. D. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.011 · Cited by 29
Genetic Linkage in Bipolar Disorder
Mathews, C. A., & Reus, V. I. (2003) · CNS Spectrums · doi:10.1017/s1092852900028686 · Cited by 31
“Because of the problems in identifying susceptibility genes for bipolar disorder, some investigators have suggested the use of endophenotypes, which may have more straightforward inheritance patterns, to further inform the genetic studies of bipolar disorder.(107) Endophenotypes traditionally include biochemical or pa…”
BackgroundMethodInfluentialVariant GADL1 and Response to Lithium in Bipolar I Disorder
Birnbaum, R., Shin, J. H., & Weinberger, D. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1401817 · Cited by 29
Papolos, D. F., Teicher, M. H., & Post, R. M. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13817 · Cited by 35
“Lithium is clinically effective in roughly half of the treated individuals, where their genetic background is known to influence treatment outcomes [67].”
Duffy, A. C., Heffer, N., Goodday, S., Weir, A., Patten, S. B., Malhi, G. S., & Cipriani, A. (2018) · Bipolar Disorders · doi:10.1111/bdi.12690 · Cited by 34
Self-citationSex Differences in Bipolar Disorders: Impact on Psychopathological Features and Treatment Response
Menculini, G., Steardo, L., Sciarma, T., D’Angelo, M., Lanza, L., Cinesi, G., Cirimbilli, F., Moretti, P., Verdolini, N., Fazio, P. D., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.926594 · Cited by 34
“For the latter, a total score ≥7 was considered as indicative of a good response to mood stabilizers, while a total score <7 was considered for lack of good treatment response (50, 51).”
BackgroundAhn, S. W., Baek, J. H., Yang, S., Kim, Y., Cho, Y., Choi, Y., Lee, K., Park, T., & Hong, K. S. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0093-5 · Cited by 34
Predicting Response to Lithium in Mood Disorders: Role of Genetic Polymorphisms
Serretti, A., & Artioli, P. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303010-00004 · Cited by 29
Treatment of bipolar disorder: New perspectives
Alda, M., Hájek, T., Calkin, C., & O’Donovan, C. (2008) · Annals of Medicine · doi:10.1080/07853890802409489 · Cited by 35
“Familiality of specific traits, such as lithium responsiveness (31) or concordance of clinical course between affected parents and children (32), provides further evidence for heterogeneity.”
BackgroundSelf-citationGenetic factors and treatment of mood disorders
Alda, M. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.30606.x · Cited by 33
Self-citationPharmacogenetics, Race, and Psychiatry: Prospects and Challenges
Jones, D. S., & Perlis, R. H. (2006) · Harvard Review of Psychiatry · doi:10.1080/10673220600642895 · Cited by 32
The Mechanisms of Lithium Action: The Old and New Findings
Sakrajda, K., & RYBAKOWSKI, J. K. (2025) · Pharmaceuticals · doi:10.3390/ph18040467 · Cited by 33
“1, with the gene GNL3 (G protein nucleolar 3), as essential for the proliferation of neuronal progenitor cells by lithium [143].”
Alda, M., Shao, L., Wang, J., de Lara, C. L., Groisman, I. J., Lebel, V., Sun, X., Duffy, A. C., Grof, P., Rouleau, G. A., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12131 · Cited by 32
“A series of phenotypic studies of responders to lithium have shown that: (i) the response to lithium appears to be longitudinally stable (24); (ii) lithium responders suffer from a more typical recurrent illness with low rates of comorbid conditions (25); (iii) they have significantly higher rates of BD among their re…”
BackgroundSelf-citationCarli, M., Weiss, F., Grenno, G., Ponzini, S., Kolachalam, S., Vaglini, F., Viaggi, C., Pardini, C., Tidona, S., Longoni, B., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230224102318 · Cited by 42
“Predictors of response to Lithium include a family history of BD and lithium response, preserved free intervals between mood episodes, classical mania-depression-interval cycles, no overt comorbidities, no mixed features, and a lower number of episodes prior to lithium introduction [13, 20, 21].”
BackgroundA Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder
Schneck, C. D., Chang, K., Singh, M. K., DelBello, M. P., & Miklowitz, D. J. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0035 · Cited by 29
“For children diagnosed with BD NOS and presenting with sub-threshold manic or mixed symptoms, first-line treatment included aripiprazole, quetiapine, risperidone, and lithium if there was a family history of a positive lithium response (Grof et al. 2002) (Fig.”
Senner, F., Kohshour, M. O., Abdalla, S. I. A., Papiol, S., & Schulze, T. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638882 · Cited by 28
“Family based studies suggested that long-term lithium treatment is a familial trait, showing that a remarkable proportion of patients who stabilize on lithium belong to lithiumresponsive families (Grof et al., 2002; Duffy et al., 2007).”
BackgroundFico, G., Anmella, G., Gómez-Ramiro, M., de Miquel, C., Hidalgo‐Mazzei, D., Manchia, M., Alda, M., González-Pinto, A. M., Carvalho, A. F., Vieta, E., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.062 · Cited by 32
Self-citationCrapanzano, C., Casolaro, I., Amendola, C., & Damiani, S. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.3.403 · Cited by 30
“Family history of bipolar disorder [12,63,75-78], as well family history of lithium response [12,79], are related”
BackgroundSmoller, J. W., & Gardner-Schuster, E. E. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0069-8 · Cited by 32
Niemsiri, V., Rosenthal, S. B., Nievergelt, C. M., Maihofer, A. X., Marchetto, M. C., Santos, R., Shekhtman, T., Alliey‐Rodriguez, N., Anand, A., Balaraman, Y., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01909-9 · Cited by 29
Self-citationManchia, M., Congiu, D., Squassina, A., Lampus, S. F., Ardau, R., Chillotti, C., Severino, G., & Zompo, M. D. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.004 · Cited by 27
Can network analysis shed light on predictors of lithium response in bipolar I disorder?
Scott, J. L., Bellivier, F., Manchia, M., Schulze, T. G., Alda, M., & Étain, B. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13163 · Cited by 28
“The Alda scale is comprised of two subscales: the A scale and the B scale (21).”
MethodSelf-citationKelsoe, J., Ou, A., Rosenthal, S., Adli, M., Akiyama, K., Akula, N., Alda, M., Amare, A. T., Ardau, R., Arias, B., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02811-4 · Cited by 27
“This fi nding is also supported by family studies, which found that the relatives of lithium responders were signi fi cantly more likely to be lithium responders as well [18, 19].”
Self-citationMatching the Bipolar Patient and the Mood Stabilizer
Gelenberg, A. J., & Pies, R. W. (2003) · Annals of Clinical Psychiatry · doi:10.1023/b:acli.0000008174.46414.a4 · Cited by 27
Papadima, E. M., Niola, P., Melis, C., Pisanu, C., Congiu, D., Cruceanu, C., López, J. P., Turecki, G., Ardau, R., Severino, G., et al. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0938-5 · Cited by 25
“Briefly, the sample comprised 20 BDI patients characterized as R (n = 10) and NR (n = 10) according the Alda scale (Grof et al. 2002).”
Pharmacogenetics and bipolar disorder
Mamdani, F., Groisman, I. J., Alda, M., & Turecki, G. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500245 · Cited by 24
Self-citationMilanesi, E., Voinsky, I., Hadar, A., Srouji, A., Maj, C., Shekhtman, T., Gershovits, M., Gilad, S., Chillotti, C., Squassina, A., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1372629 · Cited by 26
“Lithium response was evaluated by using the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with BD score, known as the Alda score (Grof et al. 2002).”
MethodPharmacogenomics of Lithium Response in Bipolar Disorder
Vecera, C. M., Fries, G. R., Shahani, L., Soares, J. C., & Machado‐Vieira, R. (2021) · Pharmaceuticals · doi:10.3390/ph14040287 · Cited by 23
“Response was defined using the Alda scale [11,15,34].”
BackgroundMethodInfluentialGenomics of Lithium Action and Response
Pickard, B. S. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0554-7 · Cited by 24
“The phenotypic definition of lithium response at the level of the patient is most often achieved using the ‘Alda’ rating scale based on case notes and prescription history [17].”
BackgroundMethodFries, G. R., Colpo, G. D., Monroy‐Jaramillo, N., Zhao, J., Zhao, Z., Arnold, J. G., Bowden, C. L., & Walss‐Bass, C. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.09.003 · Cited by 25
“…the responsiveness to lithium has been particularly investigated in genomic studies and point to the existence of a distinct, more homogenous phenotype within BD patients (Alda et al., 2005; Grof et al., 2002; Scott et al., 2017) that appears to be stable across life (Berghofer et al., 2013).”
BackgroundInfluentialPerugi, G., Cesari, D., Vannucchi, G., Maccariello, G., Barbuti, M., de Bartolomeis, A., Fagiolini, A. M., & Maina, G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.01.035 · Cited by 24
An ecological study of objective rest–activity markers of lithium response in bipolar-I-disorder
Scott, J. L., Hennion, V., Meyrel, M., Bellivier, F., & Étain, B. (2020) · Psychological Medicine · doi:10.1017/s0033291720004171 · Cited by 24
“…are plausible models that suggest Li effects on e.g. dopamine, inositol, or glycogen synthase kinase 3-beta, which may play a prominent role in the regulation of several circadian genes necessary for stable and organized CR (Bellivier et al., 2015; Etain et al., 2011; Harwood, 2005; McClung, 2013).”
BackgroundLithium Treatment in Children and Adolescents
Duffy, A., & Grof, P. (2018) · Pharmacopsychiatry · doi:10.1055/a-0575-4179 · Cited by 22
“In closing, based on our experience studying and treating families with affected relatives across generations over decades, we must emphasize the importance of understanding the nature of psychiatric illness segregating in the family and when possible the treatment response of individual affected members [11, 58, 59].”
BackgroundSelf-citationPharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder
Squassina, A., Manchia, M., & Zompo, M. D. (2010) · Human Genomics and Proteomics · doi:10.4061/2010/159761 · Cited by 24
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
Cho, C., Ahn, Y. M., Kim, S. J., Ha, T. H., Jeon, H. J., Cha, B., Moon, E., Park, D. Y., Baek, J. H., Kang, H., et al. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.1.100 · Cited by 26
Woo, Y. S., Yoon, B.-H., Song, J.-H., Seo, J. S., Nam, B., Lee, K., Lee, J., Jung, Y., Kim, M.-D., Lee, J. G., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227217 · Cited by 23
“, the B scale score exceeds the A scale score) is recorded as 0 [13].”
BackgroundMethodInfluentialFolley, B. S., Doop, M. L., & Park, S. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.08.019 · Cited by 26
Clinical factors associated with lithium treatment response in bipolar disorder patients from India
Kapur, V., Nadella, R. K., Raghuraman, B. S., Saraf, G., Mishra, S., Srinivasmurthy, N., Jain, S., Zompo, M. D., & Viswanath, B. (2018) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2018.04.006 · Cited by 22
Tekdemir, R., Selvı, Y., Altınbaş, K., & Koçak, N. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.034 · Cited by 26
Ulrichsen, A., Hampsey, E., Taylor, R. H., Gadelrab, R., Strawbridge, R., & Young, A. H. (2023) · BJPsych Open · doi:10.1192/bjo.2023.64 · Cited by 23
Genes involved in stress response influence lithium efficacy in bipolar patients
Szczepankiewicz, A., Narożna, B., RYBAKOWSKI, J. K., Kliwicki, S., Czerski, P. M., Dmitrzak‐Węglarz, M., Skibińska, M., Hauser, J., & Pawlak, J. (2018) · Bipolar Disorders · doi:10.1111/bdi.12639 · Cited by 23
Identification of potential genetic risk factors for bipolar disorder by whole-exome sequencing
Husson, T., Duboc, J.-B., Quenez, O., Charbonnier, C., Rothärmel, M., Cuenca, M., Jegouzo, X., Richard, A., Frébourg, T., Deleuze, J., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0291-7 · Cited by 21
Zinc finger proteins in psychiatric disorders and response to psychotropic medications
Squassina, A., Meloni, A., Chillotti, C., & Pisanu, C. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000231 · Cited by 27
“This study integrated genome-wide transcriptomic and GWAS data from a sample of bipolar disorder patients characterized for lithium response using the ‘retrospective criteria of long-term treatment response in research subjects with bipolar disorder,’ (Grof et al., 2002; Manchia et al., 2013).”
MethodSquassina, A., Niola, P., López, J. P., Cruceanu, C., Pisanu, C., Congiu, D., Severino, G., Ardau, R., Chillotti, C., Alda, M., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.03.005 · Cited by 24
Self-citationPrediction of lithium response using genomic data
Stone, W., Nunes, A., Akiyama, K., Akula, N., Ardau, R., Aubry, J., Backlund, L., Bauer, M., Bellivier, F., Cervantes, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80814-z · Cited by 26
“98) 1 (1, 1) 1 (1, 1) 1 (1, 1) ALL PPV 0.”
Self-citationCarving bipolarity using a lithium sword
Malhi, G. S., & Geddes, J. R. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148072 · Cited by 20
Menculini, G., Steardo, L., Verdolini, N., Cirimbilli, F., Moretti, P., & Tortorella, A. A. V. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.01.001 · Cited by 28
Cruceanu, C., Alda, M., Dion, P. A., Turecki, G., & Rouleau, G. A. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070855 · Cited by 20
Self-citationResponse to treatment in bipolar disorder
Cruceanu, C., Alda, M., Rouleau, G. A., & Turecki, G. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328341352c · Cited by 21
Self-citationPisanu, C., Congiu, D., Costa, M., Chillotti, C., Ardau, R., Severino, G., Angius, A., Heilbronner, U., Hou, L., McMahon, F. J., et al. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32663 · Cited by 19
“Patients with TS ≥ 7 are defined as lithium responders (LR; Grof et al., 2002; Manchia et al., 2013).”
BackgroundPisanu, C., Κάτσιλα, Θ., Patrinos, G. P., & Squassina, A. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0111 · Cited by 19
Lv, Q., Guo, Y., Zhu, M., Geng, R., Cheng, X., Bao, C., Wang, Y., Huang, X., Zhang, C., Hao, Y., et al. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1663929 · Cited by 21
“Responders to lithium were defined as the following: a YMRS score reduction of 50% or a YMRS score ˂12 in BD-M; a HAMD-17 score reduction of 50% or a HAMD-17 score ˂ 7 in BD-D (Grof et al. 2002; Machado-Vieira et al. 2013).”
MethodBarboza, A. B. C., McElroy, S. L., Veldić, M., Singh, B., Kung, S., Romo‐Nava, F., Núñez, N. A., Cabello-Arreola, A., Coombes, B. J., Prieto, M. L., et al. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-020-00184-3 · Cited by 20
Wolter, J. M., Le, B. D., Matoba, N., Lafferty, M. J., Aygün, N., Liang, D., Courtney, K. P., Song, J., Piven, J., Zylka, M. J., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.08.014 · Cited by 20
Genetics of Lithium Response in Bipolar Disorder
Papiol, S., Schulze, T. G., & Alda, M. (2018) · Pharmacopsychiatry · doi:10.1055/a-0590-4992 · Cited by 20
“Family-based studies have shown that lithium responders have typically higher rates of bipolar disorder, but not schizophrenia, among their relatives and that the response to lithium clusters in families, supporting the notion of a genetic basis of this phenotype [36, 55].”
BackgroundSelf-citationDuffy, A. C., Keown‐Stoneman, C. D. G., Goodday, S., Saunders, K., Horrocks, J., Grof, P., Weir, A., Hinds, C., & Geddes, J. R. (2018) · Bipolar Disorders · doi:10.1111/bdi.12721 · Cited by 20
Self-citationBipolar disorder in youth: An update
MEYER, S. E., & Carlson, G. A. (2003) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629386 · Cited by 18
Can, A., Piantadosi, S. C., & Gould, T. D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3045-5 · Cited by 17
“However, the therapeutic effects of lithium are limited to only some patients with bipolar disorder and depression, and clinical and epidemiological evidence indicate that lithium-responsive patients constitute a subpopulation that is probably genetically distinct from the others (Alda et al. 2005; Grof et al. 2002; M…”
Recent Findings on the Genetic Basis of Bipolar Disorder
Payne, J. L., Potash, J. B., & DePaulo, J. R. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.01.003 · Cited by 20
“The largest demonstrated a 67% response rate in family members of patients who responded to lithium, compared with 35% in relatives of patients who did not respond to lithium [129].”
ResultFellendorf, F. T., Manchia, M., Squassina, A., Pisanu, C., Dall’Acqua, S., Sut, S., Nasini, S., Congiu, D., Reininghaus, E. Z., Garzilli, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092517 · Cited by 19
“Indeed, the Alda scale was developed to evaluate the response treatment with mood stabilizers retrospectively [39,40].”
BackgroundMethod
Metadata
- Authors
- Grof, P., Duffy, A., Cavazzoni, P., Grof, E., Garnham, J., MacDougall, M., O'Donovan, C., & Alda, M.
- Affiliations
- University of Ottawa (CA)
- Dalhousie University (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-10-15
- Volume
- 63
- Issue
- 10
- Pages
- 942-947
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2136422355
- Semantic Scholar
- 5c8d39caedae6c6c21cb238faa737643cc7f8b07
- Cited by
- 438
- References
- 23
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 28 · 2023: 17 · 2022: 30 · 2021: 19 · 2020: 29 · 2019: 43 · 2018: 30 · 2017: 23 · 2016: 22 · 2015: 16 · 2014: 23 · 2013: 22 · 2012: 8
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- lithium response, bipolar disorder, family transmission, genetic susceptibility, long-term lithium therapy, treatment response
- MeSH terms
- Adult, Bipolar Disorder, Child, Dose-Response Relationship, Drug, Drug Administration Schedule, Family, Female, Humans, Lithium, Male, Middle Aged, Pharmacogenetics, Psychiatric Status Rating Scales, Retrospective Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.